

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 7.87200882 |
| 2 | nuclear pore organization (GO:0006999) | 6.78376369 |
| 3 | pore complex assembly (GO:0046931) | 5.86033321 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.18609177 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.99570774 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.99570774 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.94949298 |
| 8 | cellular response to ethanol (GO:0071361) | 4.92152800 |
| 9 | negative regulation of DNA repair (GO:0045738) | 4.89051295 |
| 10 | positive regulation of B cell differentiation (GO:0045579) | 4.87282033 |
| 11 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.85268621 |
| 12 | innate immune response in mucosa (GO:0002227) | 4.67084835 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.66825033 |
| 14 | interkinetic nuclear migration (GO:0022027) | 4.53957860 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.43663374 |
| 16 | dosage compensation (GO:0007549) | 4.41999599 |
| 17 | * B cell receptor signaling pathway (GO:0050853) | 4.26543194 |
| 18 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.25911699 |
| 19 | regulation of B cell differentiation (GO:0045577) | 4.25867700 |
| 20 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.24041812 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.16370632 |
| 22 | lipid translocation (GO:0034204) | 4.15700499 |
| 23 | phospholipid translocation (GO:0045332) | 4.15700499 |
| 24 | histone H3-K36 demethylation (GO:0070544) | 4.11600765 |
| 25 | embryonic process involved in female pregnancy (GO:0060136) | 3.95514371 |
| 26 | ribosomal small subunit assembly (GO:0000028) | 3.87149700 |
| 27 | mucosal immune response (GO:0002385) | 3.79618540 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.79069169 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.78123079 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.78123079 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 3.78123079 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 3.78123079 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 3.78123079 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.78123079 |
| 35 | regulation of pigment cell differentiation (GO:0050932) | 3.72476310 |
| 36 | protein K48-linked deubiquitination (GO:0071108) | 3.64817502 |
| 37 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.62680107 |
| 38 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.61504970 |
| 39 | antibacterial humoral response (GO:0019731) | 3.59253115 |
| 40 | organ or tissue specific immune response (GO:0002251) | 3.58109929 |
| 41 | hepatocyte apoptotic process (GO:0097284) | 3.57928121 |
| 42 | B cell mediated immunity (GO:0019724) | 3.55709429 |
| 43 | peptidyl-lysine dimethylation (GO:0018027) | 3.50770362 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 3.48789781 |
| 45 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.48769432 |
| 46 | histone H3-K9 demethylation (GO:0033169) | 3.47725575 |
| 47 | neutrophil activation involved in immune response (GO:0002283) | 3.46141817 |
| 48 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.44598945 |
| 49 | negative regulation of phagocytosis (GO:0050765) | 3.44418528 |
| 50 | nucleus localization (GO:0051647) | 3.42953187 |
| 51 | respiratory burst (GO:0045730) | 3.40611926 |
| 52 | pre-miRNA processing (GO:0031054) | 3.39129669 |
| 53 | histone lysine demethylation (GO:0070076) | 3.35865111 |
| 54 | labyrinthine layer development (GO:0060711) | 3.34588714 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.28297509 |
| 56 | positive regulation of developmental pigmentation (GO:0048087) | 3.25455968 |
| 57 | antimicrobial humoral response (GO:0019730) | 3.22848273 |
| 58 | defense response to protozoan (GO:0042832) | 3.22291783 |
| 59 | positive regulation of interferon-alpha production (GO:0032727) | 3.20550008 |
| 60 | histone demethylation (GO:0016577) | 3.18290689 |
| 61 | embryonic camera-type eye morphogenesis (GO:0048596) | 3.17532052 |
| 62 | regulation of RNA export from nucleus (GO:0046831) | 3.17032488 |
| 63 | cellular response to zinc ion (GO:0071294) | 3.16281755 |
| 64 | regulation of protein polyubiquitination (GO:1902914) | 3.15993433 |
| 65 | regulation of establishment of cell polarity (GO:2000114) | 3.14542000 |
| 66 | viral transcription (GO:0019083) | 3.11836163 |
| 67 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.11726334 |
| 68 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 3.10079283 |
| 69 | response to peptidoglycan (GO:0032494) | 3.09061535 |
| 70 | iron ion import (GO:0097286) | 3.06924987 |
| 71 | establishment of nucleus localization (GO:0040023) | 3.06873005 |
| 72 | macrophage activation involved in immune response (GO:0002281) | 3.05775113 |
| 73 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 3.05400363 |
| 74 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.05108896 |
| 75 | negative regulation of myotube differentiation (GO:0010832) | 3.05025284 |
| 76 | response to protozoan (GO:0001562) | 3.05022420 |
| 77 | regulation of interferon-alpha production (GO:0032647) | 3.03081709 |
| 78 | neutrophil activation (GO:0042119) | 3.01724466 |
| 79 | histone mRNA catabolic process (GO:0071044) | 2.99482167 |
| 80 | negative regulation of fatty acid transport (GO:2000192) | 2.97193875 |
| 81 | response to muramyl dipeptide (GO:0032495) | 2.97189057 |
| 82 | negative regulation of B cell proliferation (GO:0030889) | 2.96894634 |
| 83 | cellular extravasation (GO:0045123) | 2.96709466 |
| 84 | translational termination (GO:0006415) | 2.95082176 |
| 85 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.93879076 |
| 86 | peptidyl-threonine phosphorylation (GO:0018107) | 2.92704431 |
| 87 | definitive hemopoiesis (GO:0060216) | 2.92140206 |
| 88 | myeloid dendritic cell activation (GO:0001773) | 2.91387395 |
| 89 | T cell homeostasis (GO:0043029) | 2.91149641 |
| 90 | B cell homeostasis (GO:0001782) | 2.90544574 |
| 91 | mitotic sister chromatid cohesion (GO:0007064) | 2.89980193 |
| 92 | positive regulation of antigen processing and presentation (GO:0002579) | 2.89845052 |
| 93 | peptidyl-threonine modification (GO:0018210) | 2.89204943 |
| 94 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.88923187 |
| 95 | histone-serine phosphorylation (GO:0035404) | 2.86261327 |
| 96 | NIK/NF-kappaB signaling (GO:0038061) | 2.86228782 |
| 97 | DNA unwinding involved in DNA replication (GO:0006268) | 2.86164273 |
| 98 | negative regulation of granulocyte differentiation (GO:0030853) | 2.85505205 |
| 99 | establishment of protein localization to Golgi (GO:0072600) | 2.85199334 |
| 100 | pinocytosis (GO:0006907) | 2.84875745 |
| 101 | leukocyte aggregation (GO:0070486) | 2.83514367 |
| 102 | Golgi to endosome transport (GO:0006895) | 2.83379586 |
| 103 | lymphocyte homeostasis (GO:0002260) | 2.80715678 |
| 104 | granulocyte activation (GO:0036230) | 2.79927948 |
| 105 | DNA duplex unwinding (GO:0032508) | 2.79565812 |
| 106 | replicative senescence (GO:0090399) | 2.78925981 |
| 107 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.78296726 |
| 108 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.77674009 |
| 109 | detection of molecule of bacterial origin (GO:0032490) | 2.76658734 |
| 110 | striated muscle atrophy (GO:0014891) | 2.76597775 |
| 111 | determination of adult lifespan (GO:0008340) | 2.74559204 |
| 112 | regulation of B cell apoptotic process (GO:0002902) | 2.74413708 |
| 113 | natural killer cell differentiation (GO:0001779) | 2.73862575 |
| 114 | peptidyl-lysine trimethylation (GO:0018023) | 2.73689516 |
| 115 | positive T cell selection (GO:0043368) | 2.73457042 |
| 116 | myeloid cell activation involved in immune response (GO:0002275) | 2.73302303 |
| 117 | embryonic eye morphogenesis (GO:0048048) | 2.72473031 |
| 118 | coronary vasculature morphogenesis (GO:0060977) | 2.71934373 |
| 119 | TOR signaling (GO:0031929) | 2.71633272 |
| 120 | peptidyl-serine phosphorylation (GO:0018105) | 2.71214395 |
| 121 | germinal center formation (GO:0002467) | 2.69470782 |
| 122 | oocyte development (GO:0048599) | 2.68788385 |
| 123 | nucleus organization (GO:0006997) | 2.67836275 |
| 124 | regulation of necroptotic process (GO:0060544) | 2.67374699 |
| 125 | DNA geometric change (GO:0032392) | 2.67372002 |
| 126 | skeletal muscle adaptation (GO:0043501) | 2.66867184 |
| 127 | megakaryocyte development (GO:0035855) | 2.65864367 |
| 128 | myeloid dendritic cell differentiation (GO:0043011) | 2.65504767 |
| 129 | regulation of membrane lipid distribution (GO:0097035) | 2.65168688 |
| 130 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.63287479 |
| 131 | protein dealkylation (GO:0008214) | 2.62156605 |
| 132 | protein demethylation (GO:0006482) | 2.62156605 |
| 133 | regulation of histone H3-K9 methylation (GO:0051570) | 2.61685052 |
| 134 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.61003731 |
| 135 | translational elongation (GO:0006414) | 2.60750823 |
| 136 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.60575779 |
| 137 | natural killer cell mediated immunity (GO:0002228) | 2.60575779 |
| 138 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.60005886 |
| 139 | leukocyte homeostasis (GO:0001776) | 2.60001200 |
| 140 | mast cell activation (GO:0045576) | 2.59982864 |
| 141 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.59300678 |
| 142 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.58932478 |
| 143 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.58637489 |
| 144 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.58473637 |
| 145 | response to type I interferon (GO:0034340) | 2.58244030 |
| 146 | negative regulation of interleukin-12 production (GO:0032695) | 2.57870792 |
| 147 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.57563324 |
| 148 | response to interferon-beta (GO:0035456) | 2.55935793 |
| 149 | cellular response to type I interferon (GO:0071357) | 2.55284468 |
| 150 | type I interferon signaling pathway (GO:0060337) | 2.55284468 |
| 151 | actin nucleation (GO:0045010) | 2.55123137 |
| 152 | macroautophagy (GO:0016236) | 2.54268956 |
| 153 | positive regulation of interferon-beta production (GO:0032728) | 2.54223015 |
| 154 | lymph node development (GO:0048535) | 2.53333461 |
| 155 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.53317562 |
| 156 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.53278920 |
| 157 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.51554456 |
| 158 | response to host immune response (GO:0052572) | 2.51554456 |
| 159 | centrosome duplication (GO:0051298) | 2.51097367 |
| 160 | regulation of mast cell degranulation (GO:0043304) | 2.50844036 |
| 161 | negative regulation of histone methylation (GO:0031061) | 2.50271794 |
| 162 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.50156933 |
| 163 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.49707026 |
| 164 | chromatin assembly (GO:0031497) | 2.48849765 |
| 165 | DNA strand elongation (GO:0022616) | 2.48054840 |
| 166 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.47556904 |
| 167 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.47373652 |
| 168 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.47140355 |
| 169 | peptidyl-lysine methylation (GO:0018022) | 2.46884864 |
| 170 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.46689834 |
| 171 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 2.45863846 |
| 172 | response to host (GO:0075136) | 2.45460115 |
| 173 | response to host defenses (GO:0052200) | 2.45460115 |
| 174 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.45460115 |
| 175 | telomere maintenance via recombination (GO:0000722) | 2.45027621 |
| 176 | negative regulation of cell killing (GO:0031342) | 2.44673998 |
| 177 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.44673998 |
| 178 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.43563631 |
| 179 | protein targeting to Golgi (GO:0000042) | 2.43490457 |
| 180 | Peyers patch development (GO:0048541) | 2.43420912 |
| 181 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.43420912 |
| 182 | regulation of erythrocyte differentiation (GO:0045646) | 2.43258631 |
| 183 | early endosome to late endosome transport (GO:0045022) | 2.43246476 |
| 184 | histone H3-K4 trimethylation (GO:0080182) | 2.42782508 |
| 185 | tolerance induction (GO:0002507) | 2.42652669 |
| 186 | histone phosphorylation (GO:0016572) | 2.42605121 |
| 187 | peptidyl-serine modification (GO:0018209) | 2.42211981 |
| 188 | ribosomal small subunit biogenesis (GO:0042274) | 2.42187579 |
| 189 | regulation of antigen processing and presentation (GO:0002577) | 2.42069921 |
| 190 | fibroblast migration (GO:0010761) | 2.41705674 |
| 191 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.40501211 |
| 192 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.40371706 |
| 193 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.39220262 |
| 194 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.38214488 |
| 195 | negative regulation of inclusion body assembly (GO:0090084) | 2.36867734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.52872281 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 5.45589271 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.28524892 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.48913808 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.46919237 |
| 6 | * MYC_22102868_ChIP-Seq_BL_Human | 3.27276896 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13369671 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.10919244 |
| 9 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.94132716 |
| 10 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.87449145 |
| 11 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.84416914 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.80290733 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.56902568 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.56552342 |
| 15 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.50757731 |
| 16 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.48116403 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.47915214 |
| 18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.46488877 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42522718 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.35076300 |
| 21 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.34489707 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28805083 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.28342836 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.27403813 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15416744 |
| 26 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.12211269 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.11494748 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.07289038 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06095281 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.04864041 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.02668966 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 2.01787930 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 2.00859096 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 11.3093740 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98531852 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97247742 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.89078816 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88696481 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88073264 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86606601 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85910461 |
| 42 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.82338296 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.77593493 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76830647 |
| 45 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75510551 |
| 46 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.74081954 |
| 47 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73224666 |
| 48 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.73143233 |
| 49 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.72877105 |
| 50 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71636363 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.71115086 |
| 52 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.68350215 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.62909218 |
| 54 | TP53_16413492_ChIP-PET_HCT116_Human | 1.62720445 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60444864 |
| 56 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.59467940 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56591142 |
| 58 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.56205664 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.55263971 |
| 60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.53188298 |
| 61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.52846181 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51679305 |
| 63 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.51460088 |
| 64 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.47169328 |
| 65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.45551600 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45254901 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.44945862 |
| 68 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.44077650 |
| 69 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42507679 |
| 70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39770900 |
| 71 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39291991 |
| 72 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.38906813 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37645633 |
| 74 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.35959081 |
| 75 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.33721424 |
| 76 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.32501928 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.31544464 |
| 78 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.31239830 |
| 79 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.30453235 |
| 80 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.30433860 |
| 81 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.30427576 |
| 82 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.30253690 |
| 83 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.29879728 |
| 84 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.29879728 |
| 85 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.29661834 |
| 86 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.28973096 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28838365 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27314528 |
| 89 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27179759 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 1.26800187 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26324283 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.25709039 |
| 93 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25648981 |
| 94 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.24288187 |
| 95 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.21750937 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21696560 |
| 97 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20247137 |
| 98 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20033132 |
| 99 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19818242 |
| 100 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.17847981 |
| 101 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16820661 |
| 102 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16145975 |
| 103 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.15589322 |
| 104 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.13995736 |
| 105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13412231 |
| 106 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13271585 |
| 107 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.11404698 |
| 108 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11034020 |
| 109 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10800914 |
| 110 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10457300 |
| 111 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.10284513 |
| 112 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08890155 |
| 113 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08739787 |
| 114 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.08393208 |
| 115 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.07998827 |
| 116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07982108 |
| 117 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07463890 |
| 118 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07087900 |
| 119 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07065121 |
| 120 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06911346 |
| 121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06553707 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06496446 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06496446 |
| 124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06400563 |
| 125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06221307 |
| 126 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04802896 |
| 127 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04224693 |
| 128 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03267318 |
| 129 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.01749937 |
| 130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.01708353 |
| 131 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01590181 |
| 132 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.00194730 |
| 133 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97594417 |
| 134 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96737935 |
| 135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95780622 |
| 136 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.95529154 |
| 137 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.95379583 |
| 138 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.95094596 |
| 139 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95001622 |
| 140 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94599098 |
| 141 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94384664 |
| 142 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93139129 |
| 143 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92606787 |
| 144 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92587947 |
| 145 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92088462 |
| 146 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91356127 |
| 147 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.90895480 |
| 148 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90274365 |
| 149 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89327761 |
| 150 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.89025181 |
| 151 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88056177 |
| 152 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87896363 |
| 153 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87151622 |
| 154 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.85800267 |
| 155 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.85748387 |
| 156 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.85699861 |
| 157 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.85504322 |
| 158 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.85399832 |
| 159 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85007094 |
| 160 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84617213 |
| 161 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83655733 |
| 162 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83527695 |
| 163 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.83130157 |
| 164 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.82717117 |
| 165 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82594268 |
| 166 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.80973859 |
| 167 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.80616385 |
| 168 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.78800743 |
| 169 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.78577039 |
| 170 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.76316655 |
| 171 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.75634099 |
| 172 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74885112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.26736297 |
| 2 | MP0002009_preneoplasia | 4.11737033 |
| 3 | * MP0001800_abnormal_humoral_immune | 3.15941561 |
| 4 | MP0000685_abnormal_immune_system | 3.12201336 |
| 5 | MP0003303_peritoneal_inflammation | 3.07762473 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.99721334 |
| 7 | MP0001790_abnormal_immune_system | 2.92896567 |
| 8 | MP0005387_immune_system_phenotype | 2.92896567 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.84093233 |
| 10 | * MP0002452_abnormal_antigen_presenting | 2.82606462 |
| 11 | MP0003436_decreased_susceptibility_to | 2.78955217 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.64523437 |
| 13 | MP0005671_abnormal_response_to | 2.57332304 |
| 14 | * MP0002723_abnormal_immune_serum | 2.51934767 |
| 15 | MP0009785_altered_susceptibility_to | 2.49069639 |
| 16 | * MP0002420_abnormal_adaptive_immunity | 2.48342924 |
| 17 | * MP0001819_abnormal_immune_cell | 2.46322247 |
| 18 | MP0002419_abnormal_innate_immunity | 2.45328258 |
| 19 | MP0005025_abnormal_response_to | 2.43444003 |
| 20 | * MP0002398_abnormal_bone_marrow | 2.40923966 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.30604484 |
| 22 | MP0004808_abnormal_hematopoietic_stem | 2.30396000 |
| 23 | MP0009278_abnormal_bone_marrow | 2.28074588 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.21801033 |
| 25 | * MP0000716_abnormal_immune_system | 2.14867561 |
| 26 | * MP0000689_abnormal_spleen_morphology | 2.14808563 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 1.98949532 |
| 28 | * MP0002722_abnormal_immune_system | 1.97484512 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.96579534 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.96579534 |
| 31 | MP0002405_respiratory_system_inflammati | 1.92369742 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.92203596 |
| 33 | MP0004381_abnormal_hair_follicle | 1.91581074 |
| 34 | MP0005174_abnormal_tail_pigmentation | 1.89715007 |
| 35 | * MP0002429_abnormal_blood_cell | 1.88919405 |
| 36 | MP0001853_heart_inflammation | 1.86006325 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.85492691 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.83665040 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.81896686 |
| 40 | MP0001873_stomach_inflammation | 1.80013477 |
| 41 | MP0010307_abnormal_tumor_latency | 1.79743453 |
| 42 | MP0003693_abnormal_embryo_hatching | 1.76179148 |
| 43 | MP0010678_abnormal_skin_adnexa | 1.76124264 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.75609682 |
| 45 | MP0010094_abnormal_chromosome_stability | 1.75484095 |
| 46 | MP0005408_hypopigmentation | 1.72495028 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.71977172 |
| 48 | MP0004510_myositis | 1.68356474 |
| 49 | MP0008057_abnormal_DNA_replication | 1.66944356 |
| 50 | MP0000490_abnormal_crypts_of | 1.64208591 |
| 51 | MP0005409_darkened_coat_color | 1.62490329 |
| 52 | * MP0001845_abnormal_inflammatory_respons | 1.61845109 |
| 53 | MP0005248_abnormal_Harderian_gland | 1.58918492 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.58838632 |
| 55 | MP0003077_abnormal_cell_cycle | 1.56187838 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.53452072 |
| 57 | MP0001661_extended_life_span | 1.53403603 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.52886083 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.51286935 |
| 60 | MP0003011_delayed_dark_adaptation | 1.50524948 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 1.48816423 |
| 62 | MP0006082_CNS_inflammation | 1.48341895 |
| 63 | MP0000383_abnormal_hair_follicle | 1.47167286 |
| 64 | MP0003868_abnormal_feces_composition | 1.44557107 |
| 65 | MP0004130_abnormal_muscle_cell | 1.40640563 |
| 66 | MP0000569_abnormal_digit_pigmentation | 1.39225514 |
| 67 | * MP0004947_skin_inflammation | 1.37928795 |
| 68 | MP0003111_abnormal_nucleus_morphology | 1.37682807 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.36953418 |
| 70 | MP0002006_tumorigenesis | 1.33776956 |
| 71 | MP0003632_abnormal_nervous_system | 1.32154477 |
| 72 | MP0005187_abnormal_penis_morphology | 1.31265433 |
| 73 | MP0008260_abnormal_autophagy | 1.29356789 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.28898421 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 1.28049426 |
| 76 | MP0003866_abnormal_defecation | 1.26434336 |
| 77 | MP0002019_abnormal_tumor_incidence | 1.25190547 |
| 78 | MP0005451_abnormal_body_composition | 1.24823947 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 1.21458870 |
| 80 | MP0003045_fibrosis | 1.18679916 |
| 81 | MP0005310_abnormal_salivary_gland | 1.18629923 |
| 82 | MP0004264_abnormal_extraembryonic_tissu | 1.18202676 |
| 83 | MP0003724_increased_susceptibility_to | 1.18043734 |
| 84 | MP0008469_abnormal_protein_level | 1.17606756 |
| 85 | MP0000733_abnormal_muscle_development | 1.17102073 |
| 86 | MP0002332_abnormal_exercise_endurance | 1.15237611 |
| 87 | MP0008058_abnormal_DNA_repair | 1.14856790 |
| 88 | MP0008007_abnormal_cellular_replicative | 1.11356985 |
| 89 | MP0003566_abnormal_cell_adhesion | 1.11277885 |
| 90 | MP0004957_abnormal_blastocyst_morpholog | 1.10567898 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 1.10141867 |
| 92 | MP0005076_abnormal_cell_differentiation | 1.09011991 |
| 93 | MP0000858_altered_metastatic_potential | 1.08731116 |
| 94 | MP0005666_abnormal_adipose_tissue | 1.08506220 |
| 95 | MP0000537_abnormal_urethra_morphology | 1.08187791 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 1.06525687 |
| 97 | MP0005171_absent_coat_pigmentation | 1.06524048 |
| 98 | MP0002086_abnormal_extraembryonic_tissu | 1.06492248 |
| 99 | MP0003448_altered_tumor_morphology | 1.06119617 |
| 100 | MP0000013_abnormal_adipose_tissue | 1.03939738 |
| 101 | MP0009840_abnormal_foam_cell | 1.02115387 |
| 102 | MP0004233_abnormal_muscle_weight | 0.98463589 |
| 103 | MP0000343_altered_response_to | 0.96937036 |
| 104 | MP0003984_embryonic_growth_retardation | 0.95350628 |
| 105 | MP0002088_abnormal_embryonic_growth/wei | 0.94063924 |
| 106 | MP0003828_pulmonary_edema | 0.93398051 |
| 107 | MP0000015_abnormal_ear_pigmentation | 0.93276904 |
| 108 | MP0002095_abnormal_skin_pigmentation | 0.92123096 |
| 109 | MP0000427_abnormal_hair_cycle | 0.92005099 |
| 110 | MP0000313_abnormal_cell_death | 0.91961473 |
| 111 | MP0003890_abnormal_embryonic-extraembry | 0.90661291 |
| 112 | MP0000350_abnormal_cell_proliferation | 0.90571187 |
| 113 | MP0002075_abnormal_coat/hair_pigmentati | 0.88394778 |
| 114 | MP0002092_abnormal_eye_morphology | 0.87952016 |
| 115 | MP0000428_abnormal_craniofacial_morphol | 0.87690183 |
| 116 | MP0001851_eye_inflammation | 0.84636334 |
| 117 | MP0001186_pigmentation_phenotype | 0.84503155 |
| 118 | MP0003690_abnormal_glial_cell | 0.83256538 |
| 119 | MP0004036_abnormal_muscle_relaxation | 0.82451526 |
| 120 | MP0005275_abnormal_skin_tensile | 0.82298841 |
| 121 | MP0000377_abnormal_hair_follicle | 0.78377867 |
| 122 | MP0005023_abnormal_wound_healing | 0.75546781 |
| 123 | MP0005380_embryogenesis_phenotype | 0.75180157 |
| 124 | MP0001672_abnormal_embryogenesis/_devel | 0.75180157 |
| 125 | MP0000371_diluted_coat_color | 0.74328495 |
| 126 | MP0004084_abnormal_cardiac_muscle | 0.73766330 |
| 127 | MP0001663_abnormal_digestive_system | 0.72654224 |
| 128 | MP0005375_adipose_tissue_phenotype | 0.69382994 |
| 129 | MP0009764_decreased_sensitivity_to | 0.69346452 |
| 130 | MP0002168_other_aberrant_phenotype | 0.69214950 |
| 131 | MP0000003_abnormal_adipose_tissue | 0.68767610 |
| 132 | * MP0002933_joint_inflammation | 0.68176308 |
| 133 | MP0005384_cellular_phenotype | 0.66883060 |
| 134 | MP0003950_abnormal_plasma_membrane | 0.66554799 |
| 135 | MP0001730_embryonic_growth_arrest | 0.64794169 |
| 136 | MP0005621_abnormal_cell_physiology | 0.64241952 |
| 137 | MP0009763_increased_sensitivity_to | 0.64210073 |
| 138 | MP0000627_abnormal_mammary_gland | 0.64149629 |
| 139 | MP0005391_vision/eye_phenotype | 0.63755293 |
| 140 | MP0005253_abnormal_eye_physiology | 0.63628489 |
| 141 | MP0009115_abnormal_fat_cell | 0.63366104 |
| 142 | MP0003329_amyloid_beta_deposits | 0.63215486 |
| 143 | MP0004134_abnormal_chest_morphology | 0.62744500 |
| 144 | MP0002697_abnormal_eye_size | 0.62365957 |
| 145 | MP0001915_intracranial_hemorrhage | 0.61833279 |
| 146 | MP0000477_abnormal_intestine_morphology | 0.61804859 |
| 147 | MP0003943_abnormal_hepatobiliary_system | 0.61401470 |
| 148 | MP0002998_abnormal_bone_remodeling | 0.61215106 |
| 149 | MP0005220_abnormal_exocrine_pancreas | 0.61157978 |
| 150 | MP0003075_altered_response_to | 0.60827199 |
| 151 | MP0006054_spinal_hemorrhage | 0.60788224 |
| 152 | MP0000249_abnormal_blood_vessel | 0.59439937 |
| 153 | MP0003631_nervous_system_phenotype | 0.58394202 |
| 154 | MP0005166_decreased_susceptibility_to | 0.57436074 |
| 155 | MP0003453_abnormal_keratinocyte_physiol | 0.55827709 |
| 156 | MP0008873_increased_physiological_sensi | 0.55450520 |
| 157 | MP0002877_abnormal_melanocyte_morpholog | 0.55095458 |
| 158 | MP0003091_abnormal_cell_migration | 0.51988825 |
| 159 | MP0000598_abnormal_liver_morphology | 0.51692066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.41014661 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.99743062 |
| 3 | Agammaglobulinemia (HP:0004432) | 4.87360785 |
| 4 | * Cellulitis (HP:0100658) | 4.74099280 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.50057359 |
| 6 | Subacute progressive viral hepatitis (HP:0006572) | 4.40368889 |
| 7 | Recurrent viral infections (HP:0004429) | 4.19278924 |
| 8 | Papillary thyroid carcinoma (HP:0002895) | 4.07671136 |
| 9 | Myositis (HP:0100614) | 4.00288216 |
| 10 | Meningitis (HP:0001287) | 3.98386554 |
| 11 | Chronic otitis media (HP:0000389) | 3.95228363 |
| 12 | Recurrent bronchitis (HP:0002837) | 3.94547580 |
| 13 | Thrombocytosis (HP:0001894) | 3.86225029 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.84163464 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76332825 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.67594088 |
| 17 | * IgM deficiency (HP:0002850) | 3.66472144 |
| 18 | Dysmetric saccades (HP:0000641) | 3.63386399 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.49955986 |
| 20 | Gastrointestinal stroma tumor (HP:0100723) | 3.46005085 |
| 21 | Osteomyelitis (HP:0002754) | 3.43098782 |
| 22 | Recurrent skin infections (HP:0001581) | 3.37771259 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.27548584 |
| 24 | Vasculitis (HP:0002633) | 3.24924091 |
| 25 | Verrucae (HP:0200043) | 3.23234582 |
| 26 | Papilloma (HP:0012740) | 3.23234582 |
| 27 | Abnormality of macrophages (HP:0004311) | 3.22254357 |
| 28 | Panhypogammaglobulinemia (HP:0003139) | 3.18006240 |
| 29 | Obstructive lung disease (HP:0006536) | 3.14639826 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.14639826 |
| 31 | Orchitis (HP:0100796) | 3.03860938 |
| 32 | * Gastrointestinal inflammation (HP:0004386) | 3.02979648 |
| 33 | Petechiae (HP:0000967) | 3.00612746 |
| 34 | Lymphopenia (HP:0001888) | 2.99732337 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 2.98245752 |
| 36 | Recurrent pneumonia (HP:0006532) | 2.98244522 |
| 37 | * Inflammation of the large intestine (HP:0002037) | 2.96233770 |
| 38 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.95130620 |
| 39 | Osteolytic defects of the hand bones (HP:0009699) | 2.95130620 |
| 40 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.94810035 |
| 41 | Autoimmune thrombocytopenia (HP:0001973) | 2.93577211 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.88959981 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.88959981 |
| 44 | Recurrent lower respiratory tract infections (HP:0002783) | 2.84332999 |
| 45 | Optic neuritis (HP:0100653) | 2.81192083 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.81192083 |
| 47 | Thyroid carcinoma (HP:0002890) | 2.79468999 |
| 48 | * Colitis (HP:0002583) | 2.79376608 |
| 49 | Asymmetry of the thorax (HP:0001555) | 2.78913464 |
| 50 | Sandal gap (HP:0001852) | 2.78818435 |
| 51 | Recurrent sinusitis (HP:0011108) | 2.77872766 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.77065205 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.76854302 |
| 54 | T lymphocytopenia (HP:0005403) | 2.75684083 |
| 55 | Germ cell neoplasia (HP:0100728) | 2.75541100 |
| 56 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.75188882 |
| 57 | Absent frontal sinuses (HP:0002688) | 2.74093521 |
| 58 | Reticulocytopenia (HP:0001896) | 2.70428269 |
| 59 | Abnormality of the fingertips (HP:0001211) | 2.67843678 |
| 60 | Neonatal hypoglycemia (HP:0001998) | 2.66311738 |
| 61 | Deep philtrum (HP:0002002) | 2.64434569 |
| 62 | Abnormality of B cell number (HP:0010975) | 2.62094683 |
| 63 | B lymphocytopenia (HP:0010976) | 2.62094683 |
| 64 | Nasal polyposis (HP:0100582) | 2.61598614 |
| 65 | Abnormal platelet function (HP:0011869) | 2.59620418 |
| 66 | Impaired platelet aggregation (HP:0003540) | 2.59620418 |
| 67 | Chronic sinusitis (HP:0011109) | 2.59516412 |
| 68 | Abnormality of T cells (HP:0002843) | 2.58761655 |
| 69 | Spinal cord lesions (HP:0100561) | 2.54279267 |
| 70 | Syringomyelia (HP:0003396) | 2.54279267 |
| 71 | Sepsis (HP:0100806) | 2.52230707 |
| 72 | Emphysema (HP:0002097) | 2.49937170 |
| 73 | Pustule (HP:0200039) | 2.47474019 |
| 74 | Arterial thrombosis (HP:0004420) | 2.47139375 |
| 75 | Heterotopia (HP:0002282) | 2.47034956 |
| 76 | Agnosia (HP:0010524) | 2.44323167 |
| 77 | Increased IgE level (HP:0003212) | 2.44264549 |
| 78 | Abnormality of the nasal mucosa (HP:0000433) | 2.42428429 |
| 79 | Periodontitis (HP:0000704) | 2.41778667 |
| 80 | Scanning speech (HP:0002168) | 2.41483839 |
| 81 | Gingivitis (HP:0000230) | 2.40808788 |
| 82 | Hypopigmentation of the fundus (HP:0007894) | 2.40277299 |
| 83 | Vacuolated lymphocytes (HP:0001922) | 2.39091809 |
| 84 | Lymphoma (HP:0002665) | 2.37935591 |
| 85 | Micronodular cirrhosis (HP:0001413) | 2.37762230 |
| 86 | Short chin (HP:0000331) | 2.37323087 |
| 87 | Large earlobe (HP:0009748) | 2.34951316 |
| 88 | Abnormality of T cell number (HP:0011839) | 2.34864065 |
| 89 | Termporal pattern (HP:0011008) | 2.32851891 |
| 90 | Insidious onset (HP:0003587) | 2.32851891 |
| 91 | Hematochezia (HP:0002573) | 2.32098476 |
| 92 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.31644372 |
| 93 | Chest pain (HP:0100749) | 2.30136304 |
| 94 | Skin ulcer (HP:0200042) | 2.30087875 |
| 95 | Overgrowth (HP:0001548) | 2.28702178 |
| 96 | Encephalitis (HP:0002383) | 2.27584103 |
| 97 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.26785902 |
| 98 | Submucous cleft hard palate (HP:0000176) | 2.25672088 |
| 99 | Conjunctival telangiectasia (HP:0000524) | 2.25428906 |
| 100 | Ankyloglossia (HP:0010296) | 2.24563699 |
| 101 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.23839197 |
| 102 | Flat acetabular roof (HP:0003180) | 2.23382994 |
| 103 | Narrow palate (HP:0000189) | 2.21818194 |
| 104 | Increased cerebral lipofuscin (HP:0011813) | 2.18898646 |
| 105 | Epistaxis (HP:0000421) | 2.18466808 |
| 106 | Restrictive lung disease (HP:0002091) | 2.17704933 |
| 107 | Leukopenia (HP:0001882) | 2.17661352 |
| 108 | IgG deficiency (HP:0004315) | 2.17555765 |
| 109 | Urticaria (HP:0001025) | 2.17538818 |
| 110 | Abnormal number of erythroid precursors (HP:0012131) | 2.14892767 |
| 111 | Bronchitis (HP:0012387) | 2.13956899 |
| 112 | Truncal obesity (HP:0001956) | 2.12734153 |
| 113 | Dislocated radial head (HP:0003083) | 2.12660762 |
| 114 | Prominent nose (HP:0000448) | 2.11569864 |
| 115 | Relative macrocephaly (HP:0004482) | 2.11176942 |
| 116 | Increased density of long bones (HP:0006392) | 2.11171302 |
| 117 | Leukocytosis (HP:0001974) | 2.09693405 |
| 118 | Abnormal glucose tolerance (HP:0001952) | 2.09318942 |
| 119 | Pulmonary infiltrates (HP:0002113) | 2.08591581 |
| 120 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.08057064 |
| 121 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.08029489 |
| 122 | Amaurosis fugax (HP:0100576) | 2.07532763 |
| 123 | Acute myeloid leukemia (HP:0004808) | 2.06978977 |
| 124 | Fair hair (HP:0002286) | 2.06784621 |
| 125 | Hepatitis (HP:0012115) | 2.06070556 |
| 126 | Generalized hypopigmentation of hair (HP:0011358) | 2.02001560 |
| 127 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.01960477 |
| 128 | Abnormality of the epiphyses of the hand (HP:0005924) | 2.01643645 |
| 129 | Systemic lupus erythematosus (HP:0002725) | 2.01413082 |
| 130 | Myelodysplasia (HP:0002863) | 2.01177716 |
| 131 | Scotoma (HP:0000575) | 1.99842268 |
| 132 | Fatigue (HP:0012378) | 1.99135641 |
| 133 | Gingival bleeding (HP:0000225) | 1.99070244 |
| 134 | Difficulty running (HP:0009046) | 1.98297913 |
| 135 | Hypoplasia of the iris (HP:0007676) | 1.98043037 |
| 136 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97815950 |
| 137 | Keratoconjunctivitis sicca (HP:0001097) | 1.97708691 |
| 138 | Vertebral arch anomaly (HP:0008438) | 1.97572437 |
| 139 | Albinism (HP:0001022) | 1.97351591 |
| 140 | Menstrual irregularities (HP:0000858) | 1.97286210 |
| 141 | Pallor (HP:0000980) | 1.96541030 |
| 142 | Aortic aneurysm (HP:0004942) | 1.96257706 |
| 143 | Medulloblastoma (HP:0002885) | 1.96195199 |
| 144 | Autoimmune hemolytic anemia (HP:0001890) | 1.95924022 |
| 145 | Thoracic kyphosis (HP:0002942) | 1.95160519 |
| 146 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.94464252 |
| 147 | Abnormality of oral frenula (HP:0000190) | 1.93913632 |
| 148 | 11 pairs of ribs (HP:0000878) | 1.92808919 |
| 149 | Blue irides (HP:0000635) | 1.92555641 |
| 150 | Abnormality of the thoracic spine (HP:0100711) | 1.91916064 |
| 151 | Viral hepatitis (HP:0006562) | 1.91902162 |
| 152 | Granulocytopenia (HP:0001913) | 1.91891333 |
| 153 | Renovascular hypertension (HP:0100817) | 1.91594697 |
| 154 | Eosinophilia (HP:0001880) | 1.90955047 |
| 155 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.90529030 |
| 156 | Skin rash (HP:0000988) | 1.88180083 |
| 157 | Neutropenia (HP:0001875) | 1.86221703 |
| 158 | Abnormality of the radial head (HP:0003995) | 1.86195502 |
| 159 | Curly hair (HP:0002212) | 1.86189156 |
| 160 | Persistence of primary teeth (HP:0006335) | 1.84960750 |
| 161 | Abnormal platelet volume (HP:0011876) | 1.84903747 |
| 162 | Gastrointestinal carcinoma (HP:0002672) | 1.84326650 |
| 163 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.84326650 |
| 164 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.83964532 |
| 165 | Macroorchidism (HP:0000053) | 1.82946057 |
| 166 | Thoracolumbar scoliosis (HP:0002944) | 1.82559076 |
| 167 | Glucose intolerance (HP:0000833) | 1.81648550 |
| 168 | Bladder neoplasm (HP:0009725) | 1.80914130 |
| 169 | Bladder carcinoma (HP:0002862) | 1.80914130 |
| 170 | Broad ribs (HP:0000885) | 1.79462244 |
| 171 | Chromsome breakage (HP:0040012) | 1.78888334 |
| 172 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.77291813 |
| 173 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.77248852 |
| 174 | Short nail (HP:0001799) | 1.77009228 |
| 175 | Acute lymphatic leukemia (HP:0006721) | 1.75945823 |
| 176 | Cubitus valgus (HP:0002967) | 1.75856814 |
| 177 | Leiomyosarcoma (HP:0100243) | 1.75407416 |
| 178 | Uterine leiomyosarcoma (HP:0002891) | 1.75407416 |
| 179 | Resting tremor (HP:0002322) | 1.70257325 |
| 180 | Missing ribs (HP:0000921) | 1.68674919 |
| 181 | Sparse lateral eyebrow (HP:0005338) | 1.68126407 |
| 182 | Coarse hair (HP:0002208) | 1.67895253 |
| 183 | Central scotoma (HP:0000603) | 1.67091686 |
| 184 | Short 4th metacarpal (HP:0010044) | 1.66210451 |
| 185 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.66210451 |
| 186 | Protruding tongue (HP:0010808) | 1.64172114 |
| 187 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.63722516 |
| 188 | Esophageal varix (HP:0002040) | 1.61184190 |
| 189 | Thick eyebrow (HP:0000574) | 1.59198036 |
| 190 | Abnormality of chromosome stability (HP:0003220) | 1.57839118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.76509647 |
| 2 | TLK1 | 3.44786728 |
| 3 | ZAK | 3.24933017 |
| 4 | EEF2K | 3.06903138 |
| 5 | BLK | 2.75577335 |
| 6 | KIT | 2.68776395 |
| 7 | ERN1 | 2.67096408 |
| 8 | AKT3 | 2.67000652 |
| 9 | CSF1R | 2.65350860 |
| 10 | MAP3K10 | 2.62909406 |
| 11 | FRK | 2.44872945 |
| 12 | * BTK | 2.14518096 |
| 13 | IRAK4 | 2.03954455 |
| 14 | STK10 | 1.97315402 |
| 15 | PKN2 | 1.97048860 |
| 16 | JAK3 | 1.95682512 |
| 17 | MAP3K2 | 1.94831625 |
| 18 | RIPK4 | 1.92471637 |
| 19 | TBK1 | 1.89762645 |
| 20 | TYK2 | 1.89731018 |
| 21 | GRK6 | 1.82350051 |
| 22 | * SYK | 1.81483386 |
| 23 | PIK3CG | 1.80809517 |
| 24 | FLT3 | 1.74186129 |
| 25 | LRRK2 | 1.66455228 |
| 26 | SGK2 | 1.64897426 |
| 27 | TEC | 1.63287442 |
| 28 | IRAK3 | 1.63199601 |
| 29 | MAP3K14 | 1.62680600 |
| 30 | MST1R | 1.61863191 |
| 31 | ZAP70 | 1.61176995 |
| 32 | RPS6KA5 | 1.59802745 |
| 33 | TGFBR2 | 1.50548547 |
| 34 | FES | 1.50216588 |
| 35 | IKBKE | 1.50213524 |
| 36 | CDK12 | 1.44629439 |
| 37 | RET | 1.43838586 |
| 38 | MAP2K3 | 1.43043728 |
| 39 | IKBKB | 1.43007964 |
| 40 | MAP3K6 | 1.40311665 |
| 41 | PIM1 | 1.39130600 |
| 42 | NEK2 | 1.39073859 |
| 43 | SGK3 | 1.38290806 |
| 44 | CAMKK2 | 1.38033905 |
| 45 | NEK6 | 1.37248371 |
| 46 | TAOK3 | 1.36416576 |
| 47 | PBK | 1.35547376 |
| 48 | EPHA3 | 1.34719473 |
| 49 | CDC7 | 1.34129291 |
| 50 | NME2 | 1.32875643 |
| 51 | MATK | 1.29185055 |
| 52 | ICK | 1.24797787 |
| 53 | TRIB3 | 1.20988770 |
| 54 | RPS6KB2 | 1.20427964 |
| 55 | RPS6KA4 | 1.18583776 |
| 56 | CLK1 | 1.18320644 |
| 57 | WEE1 | 1.16033242 |
| 58 | * LYN | 1.15872206 |
| 59 | PDGFRB | 1.15744457 |
| 60 | * HCK | 1.12286079 |
| 61 | MELK | 1.11288135 |
| 62 | CDK4 | 1.10991175 |
| 63 | BMPR2 | 1.08833085 |
| 64 | MAP3K13 | 1.07979697 |
| 65 | SCYL2 | 1.05625996 |
| 66 | TGFBR1 | 1.03570362 |
| 67 | SGK223 | 1.03017367 |
| 68 | SGK494 | 1.03017367 |
| 69 | EPHB1 | 1.02940140 |
| 70 | LATS1 | 1.02892805 |
| 71 | CSK | 1.01908133 |
| 72 | * LCK | 1.01767833 |
| 73 | JAK1 | 1.01259956 |
| 74 | STK4 | 1.00516338 |
| 75 | MTOR | 0.99650795 |
| 76 | PDGFRA | 0.99428918 |
| 77 | PIK3CA | 0.99261253 |
| 78 | SIK2 | 0.96828698 |
| 79 | MARK2 | 0.94951522 |
| 80 | CHUK | 0.91580891 |
| 81 | WNK1 | 0.89923016 |
| 82 | MAP3K4 | 0.89619991 |
| 83 | MET | 0.87793667 |
| 84 | MAP2K4 | 0.86005614 |
| 85 | TXK | 0.85245413 |
| 86 | PIM2 | 0.81724191 |
| 87 | MAP3K8 | 0.80594545 |
| 88 | ITK | 0.78234220 |
| 89 | RPS6KB1 | 0.77168447 |
| 90 | ERBB2 | 0.75759375 |
| 91 | CAMK4 | 0.74493200 |
| 92 | MARK3 | 0.73719323 |
| 93 | PAK4 | 0.72943158 |
| 94 | PRPF4B | 0.71711388 |
| 95 | CDK7 | 0.69859804 |
| 96 | ATR | 0.69225731 |
| 97 | ACVR1B | 0.69165267 |
| 98 | EIF2AK3 | 0.69117496 |
| 99 | PRKAA2 | 0.68679208 |
| 100 | CAMK1D | 0.68043680 |
| 101 | FGFR4 | 0.67868178 |
| 102 | IRAK1 | 0.67687639 |
| 103 | CDK6 | 0.66733339 |
| 104 | IRAK2 | 0.66068078 |
| 105 | SGK1 | 0.65875050 |
| 106 | ALK | 0.65442107 |
| 107 | MAPKAPK3 | 0.64759963 |
| 108 | PTK6 | 0.63868340 |
| 109 | CAMKK1 | 0.63044917 |
| 110 | TRPM7 | 0.62499601 |
| 111 | RAF1 | 0.61283082 |
| 112 | TESK2 | 0.59976331 |
| 113 | FER | 0.59889356 |
| 114 | FGFR3 | 0.59818087 |
| 115 | MAPKAPK2 | 0.58744675 |
| 116 | RPS6KA6 | 0.58348934 |
| 117 | MAPK4 | 0.58154283 |
| 118 | JAK2 | 0.56359057 |
| 119 | DYRK3 | 0.56033169 |
| 120 | TSSK6 | 0.55853526 |
| 121 | STK39 | 0.55189220 |
| 122 | PASK | 0.54351140 |
| 123 | BRSK2 | 0.53953392 |
| 124 | HIPK2 | 0.53542644 |
| 125 | CSNK1A1L | 0.53343179 |
| 126 | RPS6KL1 | 0.50929920 |
| 127 | RPS6KC1 | 0.50929920 |
| 128 | PRKAA1 | 0.50409275 |
| 129 | ATM | 0.50372510 |
| 130 | TNK2 | 0.46423202 |
| 131 | CHEK2 | 0.46189046 |
| 132 | BUB1 | 0.45504255 |
| 133 | EIF2AK1 | 0.45464952 |
| 134 | MAPK11 | 0.43744520 |
| 135 | VRK1 | 0.43569951 |
| 136 | ERBB3 | 0.42877833 |
| 137 | ABL1 | 0.42325698 |
| 138 | MAP3K1 | 0.42275987 |
| 139 | STK38L | 0.42027271 |
| 140 | FGR | 0.41906544 |
| 141 | BRD4 | 0.41498745 |
| 142 | CDK9 | 0.40955800 |
| 143 | PDPK1 | 0.40475456 |
| 144 | MAP3K11 | 0.39138658 |
| 145 | MAP3K7 | 0.38083060 |
| 146 | CAMK1G | 0.38068630 |
| 147 | CDK8 | 0.37641787 |
| 148 | TTN | 0.36049594 |
| 149 | STK24 | 0.35943074 |
| 150 | PDK1 | 0.35745669 |
| 151 | AURKB | 0.35191735 |
| 152 | CHEK1 | 0.34756831 |
| 153 | KDR | 0.34392436 |
| 154 | RIPK1 | 0.34381052 |
| 155 | DAPK3 | 0.33988945 |
| 156 | MKNK1 | 0.33155963 |
| 157 | KSR1 | 0.32564180 |
| 158 | NEK9 | 0.32435363 |
| 159 | KSR2 | 0.32104804 |
| 160 | NLK | 0.30652837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Alcoholism_Homo sapiens_hsa05034 | 4.01295972 |
| 2 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.17070522 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.99775386 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.84919375 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64414706 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.21596178 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.17498468 |
| 8 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.16990170 |
| 9 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14759716 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.08924779 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 1.97904995 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84618940 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.82781017 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.79471526 |
| 15 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.76732280 |
| 16 | Endometrial cancer_Homo sapiens_hsa05213 | 1.73969756 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73436766 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71067854 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.65861183 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.62924917 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57124164 |
| 22 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.56049649 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.54281762 |
| 24 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.51590235 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.50303563 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.49878310 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48909548 |
| 28 | Thyroid cancer_Homo sapiens_hsa05216 | 1.48584987 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.44986944 |
| 30 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43404365 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42466076 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.41834002 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.40383774 |
| 34 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.38793705 |
| 35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.36686354 |
| 36 | Pertussis_Homo sapiens_hsa05133 | 1.36146740 |
| 37 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.35865110 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.35537726 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34714565 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.34266237 |
| 41 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.33411561 |
| 42 | Spliceosome_Homo sapiens_hsa03040 | 1.33113246 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31732446 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.31519217 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30802511 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.29602930 |
| 47 | * Glioma_Homo sapiens_hsa05214 | 1.27319589 |
| 48 | Prostate cancer_Homo sapiens_hsa05215 | 1.26018562 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.25204843 |
| 50 | Malaria_Homo sapiens_hsa05144 | 1.19115808 |
| 51 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.15680019 |
| 52 | Cell cycle_Homo sapiens_hsa04110 | 1.15531420 |
| 53 | Adherens junction_Homo sapiens_hsa04520 | 1.15002442 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14956689 |
| 55 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14383268 |
| 56 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.13827676 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12812699 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09651844 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.09403199 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09144562 |
| 61 | Focal adhesion_Homo sapiens_hsa04510 | 1.08323874 |
| 62 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08265991 |
| 63 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.07074984 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.04155442 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 1.02150997 |
| 66 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.02113829 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02087368 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99703318 |
| 69 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98671406 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97987881 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96976834 |
| 72 | * Platelet activation_Homo sapiens_hsa04611 | 0.96753819 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96419495 |
| 74 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.96294797 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.96033994 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.94535839 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94330482 |
| 78 | Asthma_Homo sapiens_hsa05310 | 0.91980565 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91772203 |
| 80 | RNA transport_Homo sapiens_hsa03013 | 0.90350359 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89080126 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88955147 |
| 83 | Allograft rejection_Homo sapiens_hsa05330 | 0.88675665 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.88147070 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87294804 |
| 86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86542999 |
| 87 | Melanoma_Homo sapiens_hsa05218 | 0.86482291 |
| 88 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.82702392 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81838221 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81194452 |
| 91 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79710105 |
| 92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.79386236 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.77609111 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77523658 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77327155 |
| 96 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76848171 |
| 97 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.76786496 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76434488 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76247335 |
| 100 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.75812496 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75190732 |
| 102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73609316 |
| 103 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.72788792 |
| 104 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71929753 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.71021807 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.71012939 |
| 107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68980003 |
| 108 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.68381569 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67909115 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67298847 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66545051 |
| 112 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66444432 |
| 113 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66174320 |
| 114 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66063153 |
| 115 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.65777702 |
| 116 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.64597764 |
| 117 | RNA degradation_Homo sapiens_hsa03018 | 0.63478862 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62132429 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61131473 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59031948 |
| 121 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.58228253 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57229614 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57015353 |
| 124 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.56290110 |
| 125 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55926186 |
| 126 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55406856 |
| 127 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55045193 |
| 128 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54403456 |
| 129 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53407087 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53405981 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53071839 |
| 132 | Phagosome_Homo sapiens_hsa04145 | 0.49981028 |
| 133 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48224202 |
| 134 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47802243 |
| 135 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.46755902 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.46580330 |
| 137 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45434492 |
| 138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44683180 |
| 139 | RNA polymerase_Homo sapiens_hsa03020 | 0.44548443 |
| 140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44243876 |
| 141 | Renin secretion_Homo sapiens_hsa04924 | 0.43516333 |
| 142 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42719750 |
| 143 | Tight junction_Homo sapiens_hsa04530 | 0.41837820 |
| 144 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.41826949 |
| 145 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39364524 |
| 146 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38731214 |
| 147 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37802796 |
| 148 | Insulin resistance_Homo sapiens_hsa04931 | 0.33492242 |
| 149 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33192253 |
| 150 | Proteasome_Homo sapiens_hsa03050 | 0.32218845 |
| 151 | Endocytosis_Homo sapiens_hsa04144 | 0.31956011 |
| 152 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31768355 |

